Author Question: In the new Keynesian models, a. imperfect competition comes is the result of optimizing behavior ... (Read 65 times)

ENagel

  • Hero Member
  • *****
  • Posts: 540
In the new Keynesian models,
 
  a. imperfect competition comes is the result of optimizing behavior by individuals.
  b. perfect competition is assumed with respect to the product market
  c. a natural monopoly is presumed for the product market.
  d. both a and c.
  d. None of the above

Question 2

An export industry is said to exhibit increasing returns to scale when
 
  (a) a large-scale organization has significant competitive advantages over small-scale activities.
  (b) labor utilization increases by 50 percent but export output production increases by only
  20 percent.
  (c) its small-scale business activity has significant comparative advantages over large-scale productions.
  (d) use of capital increases by 10 percent leads to an increase in export production by 10 percent.



ktidd

  • Sr. Member
  • ****
  • Posts: 319
Answer to Question 1

A

Answer to Question 2

(a)



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

About 600,000 particles of skin are shed every hour by each human. If you live to age 70 years, you have shed 105 pounds of dead skin.

Did you know?

The immune system needs 9.5 hours of sleep in total darkness to recharge completely.

Did you know?

Congestive heart failure is a serious disorder that carries a reduced life expectancy. Heart failure is usually a chronic illness, and it may worsen with infection or other physical stressors.

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library